biote Corp.
Index- P/E15.13 EPS (ttm)0.41 Insider Own23.70% Shs Outstand39.69M Perf Week33.69%
Market Cap395.11M Forward P/E10.07 EPS next Y0.61 Insider Trans-5.99% Shs Float32.89M Perf Month34.57%
Income16.20M PEG- EPS next Q0.14 Inst Own21.10% Short Float / Ratio0.22% / 0.91 Perf Quarter65.07%
Sales- P/S- EPS this Y541.70% Inst Trans7.81% Short Interest0.07M Perf Half Y49.16%
Book/sh7.46 P/B0.83 EPS next Y14.95% ROA3.50% Target Price10.67 Perf Year-37.28%
Cash/sh0.00 P/C3951.08 EPS next 5Y- ROE3.80% 52W Range2.00 - 10.52 Perf YTD65.95%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-41.19% Beta-
Dividend %- Quick Ratio0.10 Sales past 5Y- Gross Margin- 52W Low209.50% ATR0.35
Employees- Current Ratio0.10 Sales Q/Q- Oper. Margin- RSI (14)76.18 Volatility8.44% 7.18%
OptionableNo Debt/Eq0.00 EPS Q/Q129.80% Profit Margin- Rel Volume0.74 Prev Close5.66
ShortableYes LT Debt/Eq0.00 EarningsMar 28 AMC Payout0.00% Avg Volume81.05K Price6.19
Recom2.00 SMA2027.85% SMA5033.64% SMA20046.02% Volume59,709 Change9.36%
Jun-24-22Initiated Cowen Outperform $11
Jun-23-22Initiated ROTH Capital Buy $9
Mar-31-23 09:55AM
Mar-28-23 04:15PM
Mar-27-23 09:00AM
Mar-02-23 08:00AM
Feb-09-23 04:15PM
05:30PM Loading…
Jan-09-23 05:30PM
Jan-05-23 06:00AM
Nov-10-22 08:30AM
Nov-08-22 04:15PM
Nov-07-22 09:15AM
Oct-31-22 08:30AM
Oct-10-22 07:45AM
Sep-07-22 08:30AM
Aug-25-22 04:05PM
08:30AM Loading…
Aug-24-22 08:30AM
Aug-15-22 04:56PM
Aug-09-22 04:15PM
Jul-20-22 11:00AM
Jul-18-22 10:24AM
Jun-16-22 08:30AM
Jun-06-22 04:05PM
Jun-03-22 08:59AM
May-26-22 04:05PM
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irvine, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roystone Capital Management LP10% OwnerFeb 07Buy3.25375,0001,218,7502,971,566Feb 17 12:52 PM
HEYER ANDREW RDirectorJan 09Buy3.00100,000300,000345,201Jan 10 04:27 PM
HEYER ANDREW RDirectorJan 09Buy3.00100,000300,0001,473,513Jan 10 04:27 PM
Cone Stephen MarkDirectorJan 09Buy3.0083,350250,050106,823Jan 10 04:29 PM
MORRIS DEBRA LDirectorJan 09Buy3.0030,00090,00030,000Jan 10 04:31 PM
Kamdar Samar JagatChief Financial OfficerJan 09Buy3.0013,00039,00013,000Jan 10 04:33 PM
Beer Marc DDirectorJan 09Sale3.00865,3842,596,1520Jan 10 04:25 PM
Weber Teresa SueChief Executive OfficerJan 09Sale3.00865,3842,596,15285,040Jan 10 04:23 PM
Weber Teresa SueChief Executive OfficerSep 15Option Exercise0.0085,040085,040Sep 19 04:30 PM